MedPath

Gerhard Treiber

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Phase 2
Completed
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2008-10-17
Last Posted Date
2012-04-30
Lead Sponsor
Gerhard Treiber
Target Recruit Count
33
Registration Number
NCT00775073
Locations
🇩🇪

Charité, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Berlin, Germany

🇩🇪

Martin-Luther-Universitaet Halle-Wittenberg, Universitaetsklinik und Poliklinik für Innere Medizin I, Halle, Germany

🇩🇪

Zollernalbklinikum, Balingen, Germany

and more 7 locations
© Copyright 2025. All Rights Reserved by MedPath